Peter Harwin & Tomas Kiselak: Biotech's New Builders - [Joys of Compounding, EP. 42]
Our teachers today are Peter Harwin and Tomas Kiselak, the
co-founders of Fairmount Funds, and this is their first-ever interview of any
kind.
They started Fairmount aged just 30 on the belief that you could buy and hold in biotech, an idea other investors would have laughed them out of the room for. Only 14 to 17% of drugs that enter the clinic succeed, but
they believed there’s a readily identifiable moment when a drug is likely to
become a revenue-generating monopoly. Ten years later, they apply the same thinking to drugs they make themselves, and close to 95% of Fairmount’s portfolio sits in companies they’ve founded.
Tomas gives Rick and Paul a crash course in how an idea becomes a drug, from testing thousands of molecules in a dish to the trials that decide whether it reaches patients. Then he and Peter tell the story of doing it themselves, starting from a $500,000 seed check to build a better antibody, and a round of mice that all died. Years later came Apogee, which AbbVie bought for close to $11 billion. They also share the lesson from Kevin Tang they still come back to: everything starts as nothing.
Please enjoy class with Peter Harwin and Tomas Kiselak.
For the full show notes, transcript, and links to mentioned content, check out the episode page here.
-----
Become a Colossus member to get our quarterly print magazine and private audio experience, including exclusive profiles and early access to select episodes. Subscribe at colossus.com/subscribe.
-----
This episode is brought to you by Portrait Analytics - your centralized resource for AI-powered idea generation, thesis monitoring, and personalized report building.
Built by buy-side investors, for investment professionals. We work in the background, helping surface stock ideas and thesis signposts to help you monetize every insight. In short, we help you understand the story behind the stock chart, and get to "go, or no-go" 10x faster than before.
Sign-up for a free trial today at https://www.portraitresearch.com
-----
This episode is brought to you by Eight Sleep. The new Pod 6 is a smart mattress cover that fits on any bed and automatically cools or warms each side through the night, with an AI called Autopilot that learns your sleep patterns and adjusts every night to help you get deeper, more restorative sleep. It has nine times the biometric sensors of the Pod 5, tracks heart rate at 99% accuracy compared to a standard ECG, reaches your set temperature 20% faster, and runs on a hub that's half the size and fits under most bed frames. No wearables required. The Pod 6 now starts at $1,999, the lowest starting price Eight Sleep has ever offered, and comes with a 30-day home trial and free returns. Go to https://www.eightsleep.com/joys and use code JOYS for up to $200 off.
-----
Joys of Compounding is a property of Pine Grove Studios in collaboration with Colossus, LLC. For more episodes of Joys of Compounding, visit colossus.com/episodes.
Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).
Follow us on Twitter: @Buhrman_Rick | @PaulBuser | @colossusmag
Timestamps:
(00:03:44) How Peter and Tomas Met
(00:08:35) The Thesis That Drew Them Together
(00:14:35) Why Start a Firm at 30?
(00:20:05) The Distributed Pharma Model
(00:26:50) The Licensing Deal That Wasn't
(00:29:44) Tomas's Journey From Czechoslovakia
(00:35:18) Breaking Into Biotech Without a PhD
(00:39:46) Biotech 101: A Brief History
(00:43:39) The Crossover Boom and Bust
(00:48:22) From Lab Idea to Approved Drug
(00:55:32) Who Funds Biotech?
(00:59:05) Why Drugs Take So Long
(01:03:20) The Case for Building Better Drugs
(01:09:01) Building Quellis on $500,000
(01:16:01) What Building Taught Them
(01:24:13) When the Distraction Became the Focus
(01:31:56) Managing Risk Without Capping Upside
(01:39:00) The Job's Not Done
(01:43:14) Paragon, Their In-House Incubator
(01:47:42) Hiring for Grit and Humility
(01:55:33) Apogee's $11 Billion Exit
(02:01:26) Is AI Ready for Biology?
(02:06:54) Designing the Next Decade
(02:11:17) Advice for Aspiring Founders